Low-dose fractionated total body irradiation (TBI) adversely affects prognosis of patients with leukemia receiving an HLA-matched allogeneic bone marrow transplant from an unrelated donor (UD-BMT)
Open Access
- 14 November 2002
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 30 (11), 717-723
- https://doi.org/10.1038/sj.bmt.1703701
Abstract
The optimal total body irradiation (TBI) regimen for unrelated donor bone marrow transplant (UD-BMT) is unknown. In the present study we analyze the outcomes of two different TBI regimens used in our center for patients with leukemia undergoing an UD-BMT. Between January 1994 and August 2001, 99 consecutive UD-BMT patients entered this comparative study. The conditioning regimen consisted of cyclophosphamide, 120 mg/kg followed by TBI on days −3, −2 and −1. Forty-six patients received TBI 12 Gy (2 Gy, twice a day) in six fractions (HF-TBI) and 53 patients received TBI 9.90 Gy (3.30 Gy per day) fractionated over 3 days (F-TBI). End-points were transplanted-related mortality (TRM), leukemia relapse rate (LRR) and overall survival (OS). At median follow-up of 22 months (58 months for HF-TBI and 17 for F-TBI, respectively), 60 patients were alive (32 in HF-TBI sub-group and 28 in F-TBI one). The actuarial 5-year TRM was 31% for HF-TBI and 41% for F-TBI (P = 0.1), whereas the 5-year LRR was 13% for HF-TBI and 31% for F-TBI (P = 0.04). The actuarial 5-year OS was 68% for patients treated with HF-TBI and 51% for those treated with F-TBI (P = 0.02). At multivariate analysis F-TBI schedule emerged as an adverse predictor for OS (P = 0.04) and LRR (P = 0.03). These data indicate that a lower total dose of TBI appears significantly less effective in leukemia eradication and associated with worse overall survival when compared with a higher dose of radiation.Keywords
This publication has 20 references indexed in Scilit:
- Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experienceBone Marrow Transplantation, 2000
- Unrelated bone marrow transplantation in children: outcome and a comparison with sibling donor graftingBone Marrow Transplantation, 2000
- Total body irradiation correlates with chronic graft versus host disease and affects prognosis of patients with acute lymphoblastic leukemia receiving an HLA identical allogeneic bone marrow transplantInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan/ cyclophosphamide vs total body irradiation: a meta-analysisBone Marrow Transplantation, 1998
- Unrelated donor marrow transplantation for chronic myelogenous leukaemiaBritish Journal of Haematology, 1998
- Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid LeukemiaNew England Journal of Medicine, 1998
- Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experienceBone Marrow Transplantation, 1997
- COMBINED FOSCARNET-GANCICLOVIR TREATMENT FOR CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC HEMOPOIETIC STEM CELL TRANSPLANTATION1Transplantation, 1996
- Bone Marrow TransplantationNew England Journal of Medicine, 1994
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958